T. Burrow

High Impact

Professor

University of Arkansas for Medical Sciences

faculty

21 h-index 200 pubs 1,506 cited

Research Areas

Metabolism and Genetic Disorders Genomics and Rare Diseases Neurological disorders and treatments Child and Adolescent Health Mitochondrial Function and Pathology Gene expression and cancer classification Neuroscience and Neural Engineering Connective tissue disorders research

Links

ORCID Lab Website UAMS TRI Profile

Is this your profile? Verify and claim your profile

OverviewAI-generated summary

T. Burrow is a Professor at the University of Arkansas for Medical Sciences whose research focuses on rare genetic disorders, particularly those affecting metabolism and neurodevelopment. Recent publications investigate the diagnosis and management of conditions such as Gaucher disease, glycogen storage disease type IV, NDUFS3-related disorder, Wolman disease, δ-aminolevulinic acid dehydratase deficient porphyria, and ornithine transcarbamylase deficiency. These studies often involve detailed clinical insights and the design of therapeutic approaches, including gene transfer strategies.

Burrow's work also extends to understanding the genetic underpinnings of neurodevelopmental disorders, as seen in research identifying variants in the BSN gene. Collaborations with researchers at the University of Arkansas for Medical Sciences, including Carissa Rodriquez, Katie Bosanko, Murat Gökden, and Aravindhan Veerapandiyan, contribute to the breadth of this research. Burrow maintains an active laboratory website to disseminate research findings. With an h-index of 21 and over 200 publications, Burrow is recognized as a highly cited researcher.

Metrics

h-index: 21
Publications: 200
Citations: 1,506

Selected Publications

Longitudinal Observation of Children with Achondroplasia: Findings from a Global Natural History Study (ACHieve) (2026) DOI
Variants in BSN, encoding the presynaptic protein Bassoon, result in a distinct neurodevelopmental disorder with a broad phenotypic range (2025) DOI
Correction: Profound hypotonia in an infant with δ-aminolevulinic acid dehydratase deficient porphyria (2025) DOI
Variants in <i>BSN</i> , encoding the presynaptic protein Bassoon, result in a novel neurodevelopmental disorder with a broad phenotypic range (2025) DOI
Neurodevelopmental delay, musculoskeletal disorders and dysmorphia associated with a novel pathogenic interstitial deletion of chromosome 10q21.1q21.3 (2025) DOI
Profound hypotonia in an infant with δ-aminolevulinic acid dehydratase deficient porphyria (2024) DOI
04145 Profound hypotonia in a newborn with Biallelic δ-Aminolevulinic Acid Dehydratase (ALAD) mutations (2024) DOI
Design of a Phase 3 study of AAV-mediated gene transfer of ornithine transcarbamylase (OTC) in patients with late-onset OTC deficiency (2024) DOI
DESIGN OF A PHASE 3 STUDY OF AAV-MEDIATED GENE TRANSFER OF ORNITHINE TRANSCARBAMYLASE (OTC) IN PATIENTS WITH LATE-ONSET OTC DEFICIENCY (2023) DOI
Diagnosis and management of glycogen storage disease type IV, including adult polyglucosan body disease: A clinical practice resource (2023) DOI
Clinical insights from Wolman disease: Evaluating infantile hepatosplenomegaly (2022) DOI
The diagnosis and management of Gaucher disease in pediatric patients: Where do we go from here? (2022) DOI
Mitochondrial Ultrastructural Defects in NDUFS3-Related Disorder (2021) DOI
Evaluating psychosocial stressors in families of children with inborn errors of metabolism (2021) DOI